(Q39325857)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Mohd Feroz Mohd Omar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kosei Ito

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Min En Nga

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Ross Soo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Bee Keow Peh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Tuty Muliana Ismail

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Bhavin Thakkar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Yoshiaki Ito

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Manuel Salto-Tellez

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

24 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

Pathology Oncology Research

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

783-792

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729835%20AND%20SRC:MED&resulttype=core&format=json

The new World Health Organization classification of lung tumours

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Asbestos, asbestosis, and lung cancer: a critical assessment of the epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

The molecular epidemiology of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Smoking molecular damage in bronchial epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Genetic mapping in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

A personalized approach to cancer treatment: how biomarkers can help

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

The RUNX3 gene--sequence, structure and regulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Spreading of methylation within RUNX3 CpG island in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Lung tissue regeneration after induced injury in Runx3 KO mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Causal relationship between the loss of RUNX3 expression and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

RUNX3 protein is overexpressed in human basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Anthony Dipple Carcinogenesis Award. p53 from pathway to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

RUNX3 has an oncogenic role in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Detection of epidermal growth factor receptor variations by partially denaturing HPLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Runx3 expression in gastrointestinal tract epithelium: resolving the controversy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9485-5

In search of the holy grail: lung cancer biomarkers

21 January 2018

1 reference

12 December 2020

Genetic polymorphism of CYP2D6 and lung cancer risk.

1 reference

12 December 2020

Association of p53 gene mutation and telomerase activity in resectable non-small cell lung cancer

1 reference

12 December 2020

Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking status.

1 reference

12 December 2020

The effect of tobacco on lung cancer risk depends on CYP2D6 activity.

1 reference

12 December 2020

EGFR and KRAS mutations in patients with adenocarcinoma of the lung

1 reference

12 December 2020

Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines

1 reference

12 December 2020

Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer

1 reference

12 December 2020

Expression of RUNX3 protein in human lung adenocarcinoma: implications for tumor progression and prognosis

1 reference

12 December 2020

Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression

1 reference

12 December 2020

Early detection of lung cancer: role of biomarkers

1 reference

12 December 2020

Epigenetic inactivation of the RUNX3 gene in lung cancer

1 reference

12 December 2020

What are the odds that smoking will kill you?

1 reference

12 December 2020

RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.

1 reference

12 December 2020

Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens

1 reference

12 December 2020

Lung cancer detection and prevention: evidence for an interaction between smoking and genetic predisposition.

1 reference

12 December 2020

RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.

1 reference

12 December 2020

Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas

1 reference

12 December 2020